Search

everythinglearnresearchcommunity

for

Search:↓

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

EV-based drug delivery shows promise but faces challenges in standardization and scalability.

Local injections of nanosized rhEPO can speed up skin healing and improve quality after deep second-degree burns.

MK-5108 is safe and shows potential against tumors, especially alone.

Hair regrowth improved, but quality of life did not.

New lipid/fiber microplexes improve mRNA therapy for degenerative diseases by enhancing cell function and treatment effectiveness.

Developing microRNA-based treatments is hard but has potential.

Triboelectric nanogenerators can use body movement to power therapeutic treatments, potentially transforming personalized healthcare.

CTP-543 is generally safe for treating alopecia areata.

The combined treatment effectively managed severe skin issues in Olmsted syndrome.

TECAR therapy helps with pain relief, reduces inflammation, relaxes muscles, heals tissues, and is safe and effective for many conditions.

The new assay can help develop products for hair re-growth.

New retinoids are effective for various skin conditions and are being developed to have fewer side effects.

Microneedles can precisely deliver cancer treatments with fewer side effects.

China approved Sinovac's flu vaccine, Japan approved RiUP for female hair loss, and Nippon Kayaku's three cancer drugs.

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

17β-estradiol can reduce inflammation in the skin.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

NIR-II imaging effectively tracked stem cells that helped repair facial nerve defects in rats.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.